Althea Technologies, Inc. announced that it has extended its service offering to include labelling, packaging, storage and distribution of drug and biological products through its co-marketing partner, Sherpa Clinical Packaging. Sherpa, founded in 2011, is located adjacent to Althea's clinical and commercial-scale biologics and drug product manufacturing facilities. The proximity of the facilities to one another simplifies supply chain logistics for clients of each organization. Additionally, the co-marketing agreement will provide Althea's clients developing complex biologics products the option of producing, labelling and packaging of drug and biological products during a single campaign.
"Contract packaging services offered through our co-marketing partner, Sherpa, will allow our clients to meet aggressive manufacturing timelines. We are very excited to present these capabilities to our existing and potential clients," stated Valerie McDonnell, vice president, sales and marketing, Althea Technologies.
"Sherpa is pleased to be partnering with Althea to offer clients an expanded array of manufacturing and supply services that will improve time to delivery and reduce supply chain risks for our customers," said Mark Paiz, president of Sherpa Clinical Packaging.
Althea Technologies is a fully integrated, contract development and manufacturing organization that provides services for plasmid DNA, recombinant proteins, and sterile products. Located in San Diego, Califonria, Althea offers cell banking, process development, cGMP protein & plasmid production, analytical development, formulation and lyophilization development, and aseptic filling in vials & prefilled syringes for clinical development and commercialization.
Sherpa Clinical Packaging is a privately held firm specializing in providing Clinical Trial Material management services, including packaging, labelling, distribution and returns reconciliation, for pharmaceutical, biotechnology, medical device, in-vitro diagnostics and dietary supplement companies.